Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
Phase 1/2 Terminated
19 enrolled 11 charts
A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors
Phase 1/2 Terminated
13 enrolled
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps
Phase 1/2 Terminated
8 enrolled 8 charts
DUART
Phase 1/2 Terminated
26 enrolled 20 charts
Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
Phase 1/2 Terminated
25 enrolled 18 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
Phase 1/2 Terminated
15 enrolled 9 charts
Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma
Phase 1/2 Terminated
8 enrolled 16 charts
A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer
Phase 1/2 Terminated
32 enrolled
A Study of PEP503 With Radiotherapy in Combination With Concurrent Chemotherapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
12 enrolled
MnSOD
Phase 1/2 Terminated
18 enrolled 12 charts
Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma
Phase 1/2 Terminated
14 enrolled
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
Phase 1/2 Terminated
29 enrolled 16 charts
A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)
Phase 1/2 Terminated
48 enrolled 16 charts
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
Phase 1/2 Terminated
2 enrolled 4 charts
Locally Advanced Breast Cancer: Individualized Treatment Based On Tumor Molecular Characteristics
Phase 1/2 Terminated
44 enrolled 6 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
NOA-12: BIBF1120 and R-RT in Glioblastoma
Phase 1/2 Terminated
63 enrolled
Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Terminated
5 enrolled 11 charts
Vorinostat With XRT and 5-FU for Locally Advanced Adenocarcinoma of the Pancreas
Phase 1/2 Terminated
10 enrolled 12 charts
Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Phase 1/2 Terminated
4 enrolled
Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer
Phase 1/2 Terminated
8 enrolled 4 charts
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Phase 1/2 Terminated
3 enrolled
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
Phase 1/2 Terminated
Stage I/II Nasal NK Cell Lymphoma
Phase 1/2 Terminated
1 enrolled 3 charts
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
Phase 1/2 Terminated
13 enrolled 15 charts
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
Phase 1/2 Terminated
7 enrolled
Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT
Phase 1/2 Terminated
30 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled
Vorinostat Plus Radiation Therapy in Pancreatic Cancer
Phase 1/2 Terminated
3 enrolled 3 charts
Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer
Phase 1/2 Terminated
30 enrolled 13 charts
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
Phase 1/2 Terminated
4 enrolled
Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer
Phase 1/2 Terminated
34 enrolled
Safety Trial of IRESSA, Cisplatin and Radiation Therapy for Patients With Head and Neck Cancer
Phase 1/2 Terminated
29 enrolled